Guangdong Pharma And HKUST To Co-develop Targeted Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
Guangzhou Pharmaceutical Holdings Ltd. and the Hong Kong University of Science and Technology have signed a cooperation agreement to develop novel targeted anticancer drugs.